These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11336619)

  • 1. Cardioprotection: emerging pharmacotherapy.
    Gumina RJ; Jahangir A; Gross GJ; Terzic A
    Expert Opin Pharmacother; 2001 May; 2(5):739-52. PubMed ID: 11336619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
    Sheldrick A; Gray KM; Drew GM; Louttit JB
    Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemic preconditioning: present position and future directions.
    Yellon DM; Baxter GF; Garcia-Dorado D; Heusch G; Sumeray MS
    Cardiovasc Res; 1998 Jan; 37(1):21-33. PubMed ID: 9539854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of the Na+/H+ exchanger contributes to cardiac damage following ischaemia and reperfusion.
    Allen DG; Xiao XH
    Clin Exp Pharmacol Physiol; 2000 Sep; 27(9):727-33. PubMed ID: 10972541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
    Das B; Sarkar C
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?
    Yellon DM; Baxter GF
    Heart; 2000 Apr; 83(4):381-7. PubMed ID: 10722532
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.
    Sack MN; Yellon DM
    J Am Coll Cardiol; 2003 Apr; 41(8):1404-7. PubMed ID: 12706939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote vs. local ischaemic preconditioning in the rat heart: infarct limitation, suppression of ischaemic arrhythmia and the role of reactive oxygen species.
    Galagudza MM; Sonin DL; Vlasov TD; Kurapeev DI; Shlyakhto EV
    Int J Exp Pathol; 2016 Feb; 97(1):66-74. PubMed ID: 26990944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of propofol and sevoflurane in ischemic and reperfused rat hearts: role of K(ATP) channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide).
    Mathur S; Farhangkhgoee P; Karmazyn M
    Anesthesiology; 1999 Nov; 91(5):1349-60. PubMed ID: 10551586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ethylisopropyl amiloride, a Na+ - H+ exchange inhibitor, on cardioprotective effect of ischaemic and angiotensin preconditioning.
    Sharma A; Singh M
    Mol Cell Biochem; 2000 Nov; 214(1-2):31-8. PubMed ID: 11195787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalational anaesthetics and cardioprotection.
    Weber NC; Schlack W
    Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of the myocardium during ischemia and reperfusion : Na(+)/H(+) exchange inhibition versus ischemic preconditioning.
    Avkiran M
    Circulation; 1999 Dec 21-28; 100(25):2469-72. PubMed ID: 10604882
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardioprotection associated with preconditioning in the anesthetized ferret.
    Gomoll AW
    Basic Res Cardiol; 1996; 91(6):433-43. PubMed ID: 8996628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure.
    Karmazyn M; Sostaric JV; Gan XT
    Drugs; 2001; 61(3):375-89. PubMed ID: 11293648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.
    Hausenloy DJ; Yellon DM
    Cardiovasc Res; 2004 Feb; 61(3):448-60. PubMed ID: 14962476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection: chances and challenges of its translation to the clinic.
    Heusch G
    Lancet; 2013 Jan; 381(9861):166-75. PubMed ID: 23095318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. There is more to life than revascularization: therapeutic targeting of myocardial ischemia/reperfusion injury.
    Bell RM; Yellon DM
    Cardiovasc Ther; 2011 Dec; 29(6):e67-79. PubMed ID: 20645988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.